Immune Homeostasis in Sepsis and Septic Shock
NCT04448951 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2024-08-21
Summary
Detailed description of immune response and its dynamics in sepsis and septic shock patiens by means of transcriptomics, flow-cytometry and cytokine analysis.
Conditions
- Sepsis
- Immunologic Paralysis
- Immunologic Suppression
- Immune Deficiency
Interventions
- OTHER
-
transcriptomics
transcriptomics
- OTHER
-
flow-cytometry
peripheral blood myeloid cells and lymphocytes flow-cytometry
- OTHER
-
cytokines
peripheral blood cytokine analysis
Sponsors & Collaborators
-
Charles University, Czech Republic
lead OTHER
Principal Investigators
-
Thomas Karvunidis, MD, PhD · Carles University Teaching Hospital and Faculty of Medicine in Pilsen, Pilsen, Czech Republic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2025-08-31
- Completion
- 2027-12-31
Countries
- Czechia
Study Locations
More Related Trials
-
Acute Phase Proteins as Early Markers in Sepsis
NCT00641355 ·Status: UNKNOWN
-
Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony Stimulating Factor (GM-CSF) in Patients With Severe Sepsis and Septic Shock
NCT00252915 ·Status: COMPLETED ·Phase: PHASE2
-
Dissecting How Peripheral Lymphocytes Are Lost During Sepsis
NCT03289312 ·Status: UNKNOWN
-
Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections
NCT00934011 ·Status: COMPLETED ·Phase: NA
-
Immune Function Monitoring and Immunotherapy in Sepsis
NCT04903405 ·Status: UNKNOWN
-
The Effects of Interferon-gamma on Sepsis-induced Immunoparalysis
NCT01649921 ·Status: COMPLETED ·Phase: PHASE3
-
Dynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis Patients
NCT02883218 ·Status: COMPLETED
-
Host Dysregulation-Driven Sepsis Prediction Model
NCT06523075 ·Status: COMPLETED
-
Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture.
NCT01450358 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis
NCT03314831 ·Status: COMPLETED
-
Pediatric Immune Response to Infectious Shock
NCT02848144 ·Status: COMPLETED ·Phase: NA
-
Immune Profile of Patients With Sepsis
NCT04163705 ·Status: UNKNOWN
-
Alterations of Immunologic Mediators During Severe Sepsis
NCT00484146 ·Status: TERMINATED
-
Early Identification of Sepsis in Children
NCT03884595 ·Status: UNKNOWN
-
Descriptive Study of the Evolution in Proportion of Regulatory B Lymphocytes in Patients Hospitalized in Intensive Care for Severe Sepsis
NCT03115125 ·Status: UNKNOWN ·Phase: NA
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Immunomodulatory Properties of Ketamine in Sepsis
NCT01089361 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prognostic Interest of Leucocyte Immunophenotyping During the Acute Phase of Sepsis
NCT01995448 ·Status: COMPLETED
-
Mitochondrial Function of Immune Cells in Sepsis
NCT01600989 ·Status: COMPLETED
-
Procalcitonin Monitoring Sepsis Study
NCT01523717 ·Status: COMPLETED
-
Detection Of Monocytes/Macrophages Function And Tim-3 Expression In Septic Patients
NCT01801839 ·Status: COMPLETED
-
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
NCT01535534 ·Status: UNKNOWN
-
Analysis of Immune Response In Bacterial Infection of Obese Subject
NCT02882568 ·Status: COMPLETED ·Phase: NA
-
Inflammatory Mediators in Early Sepsis
NCT02692118 ·Status: UNKNOWN
-
Evaluation of Sepsis-induced Immunosuppression Base on QuantiFERON Monitor® in Septic Shock
NCT04320394 ·Status: WITHDRAWN ·Phase: NA